← Back to Search

Behavioural Intervention

Brain Stimulation for Depression

N/A
Recruiting
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up epilepsy patients: 10 days; depression: 2 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to better understand depression by studying brain activity in patients with epilepsy and treatment-resistant depression. The researchers are using advanced artificial intelligence techniques to analyze the data and develop new treatment strategies. Their goal

Who is the study for?
This trial is for adults with refractory epilepsy scheduled for seizure monitoring and patients already enrolled in a deep brain stimulation (DBS) trial for treatment-resistant depression. Participants must consent to the study.
What is being tested?
The study tests how brain activity relates to mood states using intracranial recordings and stimulation, alongside advanced AI models. It aims to improve understanding of depression's neurobiology and refine neuromodulatory treatments.
What are the potential side effects?
While specific side effects are not listed, brain stimulation procedures may include risks such as discomfort at the electrode site, headache, nausea, or other potential neurological effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~epilepsy patients: 10 days; depression: 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and epilepsy patients: 10 days; depression: 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Daily Mood Assessment - CAT-DI
Secondary study objectives
Intracranial EEG Neural Recordings for Mood and Behavioral Assessments

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Epilepsy CohortExperimental Treatment1 Intervention
Group II: Depression CohortExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of MinnesotaOTHER
1,439 Previous Clinical Trials
1,621,900 Total Patients Enrolled
13 Trials studying Epilepsy
513 Patients Enrolled for Epilepsy
Baylor College of MedicineLead Sponsor
1,028 Previous Clinical Trials
6,030,104 Total Patients Enrolled
4 Trials studying Epilepsy
309 Patients Enrolled for Epilepsy
University of TexasOTHER
189 Previous Clinical Trials
142,910 Total Patients Enrolled
~39 spots leftby Mar 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top